BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Summary

Article discusses BMS's new manufacturing facility and a Recursion-Genentech partnership, along with infectious disease topics including long-COVID and Candida auris. No specific clinical or financial details are provided.